COLAVSGTBP• 28 Days (Normalized)
COLA vs GTBP (Columbus Acquisition Corp vs GT Biopharma Inc.)
Showing Closing Date Range from Sep 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
COLA Performance $7.3
-31.13%
Columbus Acquisition Corp
Normalized Baseline0.00%
GTBP Performance $6.88
+%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-31.13 pts
GTBP outperforming by 31.13 percentage points
COLAGTBP
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
COLA GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(18 dates)
| Date | COLA Price | COLA Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 30, 2026 | $7.30 | -31.13% | $- | - | |
| Sep 29, 2026 | $10.45 | -1.42% | $6.88 | +2752.70% | -2754.12% |
| Sep 28, 2026 | $10.64 | +0.36% | $6.80 | +2721.58% | -2721.22% |
| Sep 25, 2026 | $10.45 | -1.42% | $6.89 | +2758.92% | -2760.34% |
| Sep 24, 2026 | $10.70 | +0.94% | $6.83 | +2734.02% | -2733.08% |
| Sep 23, 2026 | $10.70 | +0.94% | $7.10 | +2846.06% | -2845.12% |
| Sep 22, 2026 | $10.74 | +1.32% | $- | - | |
| Sep 21, 2026 | $11.25 | +6.13% | $7.18 | +2879.25% | -2873.12% |
| Sep 18, 2026 | $10.70 | +0.94% | $7.16 | +2870.95% | -2870.01% |
| Sep 17, 2026 | $10.65 | +0.47% | $7.49 | +3007.88% | -3007.41% |
| Sep 16, 2026 | $10.83 | +2.17% | $7.81 | +3140.66% | -3138.49% |
| Sep 15, 2026 | $10.66 | +0.57% | $9.00 | +3634.44% | -3633.87% |
| Sep 14, 2026 | $10.76 | +1.51% | $11.63 | +4725.73% | -4724.22% |
| Sep 11, 2026 | $10.61 | +0.09% | $8.61 | +3472.61% | -3472.52% |
| Sep 10, 2026 | $8.30 | -21.70% | $6.18 | +2464.32% | -2486.02% |
Page 1 of 2